Harbin Pharmaceutical Group Co Ltd (600664) — Free Cash Flow Generation Index
Harbin Pharmaceutical Group Co Ltd (600664) has a Free Cash Flow Generation Index of 0.94x as of June 2025. Free cash flow of CN¥302.84 Million represents 1% of operating cash flow (CN¥323.33 Million). Read Harbin Pharmaceutical Group Co Ltd (600664) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1998–2024)
Historical FCF Generation Index trend for Harbin Pharmaceutical Group Co Ltd across 23 annual periods. Explore Harbin Pharmaceutical Group Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year Free Cash Flow Generation Index for Harbin Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Harbin Pharmaceutical Group Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.87x | CN¥691.69 Million | CN¥792.50 Million | CN¥100.81 Million | ▼ -4.0% |
| 2023 | 0.91x | CN¥863.14 Million | CN¥949.67 Million | CN¥86.54 Million | ▲ +6.2% |
| 2022 | 0.86x | CN¥532.45 Million | CN¥622.09 Million | CN¥89.65 Million | ▲ +2.5% |
| 2018 | 0.84x | CN¥578.61 Million | CN¥692.72 Million | CN¥114.11 Million | ▲ +164.0% |
| 2017 | 0.32x | CN¥47.21 Million | CN¥149.22 Million | CN¥102.01 Million | ▼ -67.1% |
| 2016 | 0.96x | CN¥2.67 Billion | CN¥2.78 Billion | CN¥107.46 Million | ▲ +16.5% |
| 2015 | 0.82x | CN¥1.37 Billion | CN¥1.66 Billion | CN¥290.75 Million | ▲ +23.2% |
| 2014 | 0.67x | CN¥760.73 Million | CN¥1.14 Billion | CN¥375.37 Million | ▲ +141.6% |
| 2013 | -1.61x | CN¥-228.26 Million | CN¥141.64 Million | CN¥369.90 Million | ▼ -418.7% |
| 2012 | 0.51x | CN¥282.05 Million | CN¥557.83 Million | CN¥275.78 Million | ▼ -31.7% |
| 2010 | 0.74x | CN¥853.47 Million | CN¥1.15 Billion | CN¥299.19 Million | ▼ -15.8% |
| 2009 | 0.88x | CN¥1.63 Billion | CN¥1.85 Billion | CN¥223.26 Million | ▲ +16.8% |
| 2008 | 0.75x | CN¥435.50 Million | CN¥578.59 Million | CN¥143.09 Million | ▲ +3.0% |
| 2007 | 0.73x | CN¥475.17 Million | CN¥650.16 Million | CN¥175.00 Million | ▲ +31.0% |
| 2006 | 0.56x | CN¥411.81 Million | CN¥738.08 Million | CN¥326.28 Million | ▲ +34.6% |
| 2005 | 0.41x | CN¥314.15 Million | CN¥757.76 Million | CN¥443.61 Million | ▲ +122.1% |
| 2004 | -1.88x | CN¥-279.59 Million | CN¥149.01 Million | CN¥428.60 Million | ▼ -232.5% |
| 2003 | -0.56x | CN¥-170.89 Million | CN¥302.83 Million | CN¥473.73 Million | ▼ -2752.2% |
| 2002 | -0.02x | CN¥-7.59 Million | CN¥383.44 Million | CN¥391.03 Million | ▲ +61.6% |
| 2001 | -0.05x | CN¥-31.15 Million | CN¥604.13 Million | CN¥635.28 Million | ▲ +31.5% |
| 2000 | -0.08x | CN¥-40.80 Million | CN¥541.70 Million | CN¥582.49 Million | ▼ -113.2% |
| 1999 | 0.57x | CN¥246.79 Million | CN¥431.22 Million | CN¥184.43 Million | ▲ +5.0% |
| 1998 | 0.55x | CN¥120.69 Million | CN¥221.41 Million | CN¥100.73 Million | — |